Dahlman Rose has published a research report on Baker Hughes, Inc. BHI after the company reported 3Q earnings that exceeded expectations, a welcome surprise after the company's lacking 2Q.
In the report, Dahlman Rose writes "BHI reported 3Q10 EPS of $0.58, vs our estimate of $0.43 and consensus of $0.46. The third quarter was characterized by strong top line growth driven by a pickup in North American and international activity. Higher fixed costs weighed on margins in a number of regions, especially those whose activities were weaker in 3Q10, like Africa and Norway. Despite these headwinds, the company set a road map for cost reductions to address redundancies/inefficiencies, including the elimination of overlapping regional management structures and better control of supply chain costs."
Dahlman Rose maintains its Buy rating and $74 price target.
Baker Hughes, Inc. closed yesterday at $48.37.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in